Life Sciences Solutions — Purchases of property, plant and equipment

Business Segments · Purchases of property, plant and equipment

Thermo Fisher Scientific Life Sciences Solutions — Purchases of property, plant and equipment increased by 18.5% to $32.00M in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 18.5%, from $27.00M to $32.00M.

Analysis

StatementSegment
CategoryCapital Allocation
SignalContext dependent
VolatilityModerate
First reportedQ1 2023
Last reportedQ3 2025

How to read this metric

Higher spending typically signals growth initiatives or capacity expansion, whereas lower spending may indicate a focus on cash preservation or sufficient existing capacity.

Detailed definition

This metric measures the cash outflows for capital expenditures specifically directed toward the Life Sciences Solutions...

Peer comparison

Comparable to segment-level capital expenditure (CapEx) metrics reported by peers in the scientific instrumentation and life sciences supply industry.

Metric ID: tmo_segment_life_sciences_solutions_purchases_of_property_plant_and_equipment

Historical Data

6 periods
 Q1 '23Q2 '23Q3 '23Q4 '23Q3 '24Q3 '25
Value$44.50M$44.50M$44.50M$44.50M$27.00M$32.00M
QoQ Change+0.0%+0.0%+0.0%-39.3%+18.5%
YoY Change-39.3%+18.5%
Range$27.00M$44.50M
CAGR-23.2%
Avg YoY Growth-10.4%
Median YoY Growth-10.4%

Frequently Asked Questions

What is Thermo Fisher Scientific's life sciences solutions — purchases of property, plant and equipment?
Thermo Fisher Scientific (TMO) reported life sciences solutions — purchases of property, plant and equipment of $32.00M in Q3 2025.
How has Thermo Fisher Scientific's life sciences solutions — purchases of property, plant and equipment changed year-over-year?
Thermo Fisher Scientific's life sciences solutions — purchases of property, plant and equipment increased by 18.5% year-over-year, from $27.00M to $32.00M.
What does life sciences solutions — purchases of property, plant and equipment mean?
The amount of money spent on new physical assets and infrastructure for the Life Sciences Solutions segment.

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.